Quantitative analysis of mast cells in benign and malignant colonic lesions: immunohistochemical study on formalin-fixed, paraffin-embedded tissues

被引:15
作者
Kashiwase, Y. [1 ]
Inamura, H. [1 ]
Morioka, J. [1 ]
Ilgarashi, Y. [1 ]
Kawai-Kowase, K. [1 ]
Kurosawa, M. [1 ]
机构
[1] Shin Ohra Hosp, Gunma Inst Allergy & Asthma, Ohra, Gunma 3700615, Japan
关键词
Colonic cancer; Inflammatory bowel disease; Mast cell; Tryptase; Ulcerative colitis;
D O I
10.1016/S0301-0546(08)75222-4
中图分类号
R392 [医学免疫学];
学科分类号
100102 [免疫学];
摘要
Background: Comparison of the number of mast cells in the active stage and that in remission in the same patients with ulcerative colitis with immunohistochemical staining remains to be elucidated, and analysis of the number of mast cells in benign and malignant colonic lesions is insufficient. Methods: Using immunohistochemical methods, morphological examinations of mast cells were undertaken in colonic tissues from 8 patients with ulcerative colitis and 10 patients with colonic primary cancer, which were formalin-fixed and paraffin-embedded. Changes in the number of mast cells in the active stage and in remission in the same patients with ulcerative colitis were investigated. Then, the number of mast cells in malignant tissues and adjacent healthy tissues obtained from the same patients with colonic primary cancer were compared, and finally the number of mast cells was compared among the samples from benign and malignant colonic lesions. Results: Accumulation of mast cells was found to be significant in the active stage of ulcerative colitis compared with remission in the same patients. The number of mast cells in colonic primary cancer was significantly increased compared with that in adjacent healthy tissues. The number of mast cells in ulcerative colitis was significantly greater than that in adjacent healthy tissues from patients with colonic primary cancer, irrespective of the stages of ulcerative colitis. Conclusions: We were the first to analyse mast cells in the active stage and in remission in the same patients with ulcerative colitis using immunohistochemical methods, and compared the number of mast cells between benign and malignant colonic lesions.
引用
收藏
页码:271 / 276
页数:6
相关论文
共 25 条
[1]
Tumour angiogenesis and mast cell density in the prognostic assessment of colorectal carcinomas [J].
Acikalin, MF ;
Öner, Ü ;
Topçu, I ;
Yasar, B ;
Kiper, H ;
Colak, E .
DIGESTIVE AND LIVER DISEASE, 2005, 37 (03) :162-169
[2]
Barczyk M, 1995, Rocz Akad Med Bialymst, V40, P36
[3]
LAMINA PROPRIA EOSINOPHILS AND MAST-CELLS IN ULCERATIVE-COLITIS - COMPARISON BETWEEN ASIANS AND CAUCASIANS [J].
BENFIELD, GFA ;
BRYAN, R ;
CROCKER, J .
JOURNAL OF CLINICAL PATHOLOGY, 1990, 43 (01) :27-31
[4]
Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease [J].
Bischoff, SC ;
Wedemeyer, J ;
Herrmann, A ;
Meier, PN ;
Trautwein, C ;
Cetin, Y ;
Maschek, H ;
Stolte, M ;
Gebel, M ;
Manns, MP .
HISTOPATHOLOGY, 1996, 28 (01) :1-13
[5]
AN EVALUATION OF THE AMERICAN-JOINT-COMMITTEE (PTNM) STAGING METHOD FOR CANCER OF THE COLON AND RECTUM [J].
CHAPUIS, PH ;
DENT, OF ;
NEWLAND, RC ;
BOKEY, EL ;
PHEILS, MT .
DISEASES OF THE COLON & RECTUM, 1986, 29 (01) :6-10
[6]
IMMUNOENZYMATIC LABELING OF MONOCLONAL-ANTIBODIES USING IMMUNE-COMPLEXES OF ALKALINE-PHOSPHATASE AND MONOCLONAL ANTI-ALKALINE PHOSPHATASE (APAAP COMPLEXES) [J].
CORDELL, JL ;
FALINI, B ;
ERBER, WN ;
GHOSH, AK ;
ABDULAZIZ, Z ;
MACDONALD, S ;
PULFORD, KAF ;
STEIN, H ;
MASON, DY .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1984, 32 (02) :219-229
[7]
CRAIG SS, 1986, AM J PATHOL, V124, P427
[8]
PROGNOSTIC-SIGNIFICANCE OF EOSINOPHILS AND MAST-CELLS IN RECTAL-CANCER - FINDINGS FROM THE NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT (PROTOCOL R-01) [J].
FISHER, ER ;
PAIK, SM ;
ROCKETTE, H ;
JONES, J ;
CAPLAN, R ;
FISHER, B .
HUMAN PATHOLOGY, 1989, 20 (02) :159-163
[9]
ENHANCEMENT OF HUMAN INTESTINAL MAST-CELL MEDIATOR RELEASE IN ACTIVE ULCERATIVE-COLITIS [J].
FOX, CC ;
LAZENBY, AJ ;
MOORE, WC ;
YARDLEY, JH ;
BAYLESS, TM ;
LICHTENSTEIN, LM .
GASTROENTEROLOGY, 1990, 99 (01) :119-124
[10]
CORTICOSTEROID TREATMENT REDUCES MAST-CELL NUMBERS IN INFLAMMATORY BOWEL-DISEASE [J].
GOLDSMITH, P ;
MCGARITY, B ;
WALLS, AF ;
CHURCH, MK ;
MILLWARDSADLER, GH ;
ROBERTSON, DAF .
DIGESTIVE DISEASES AND SCIENCES, 1990, 35 (11) :1409-1413